HIV-Associated Kaposi Sarcoma and Gender

Gender Medicine

Volumn 4, Issue 3, 2007, Pages 266-273

  Wang, Jayson ^a   Stebbing, Justin ^a   Bower, Mark ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

AIDS; HIV; Kaposi sarcoma; women

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; KAPOSI SARCOMA; MEDLINE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMORBIDITY; FEMALE; HERPESVIRUS 8, HUMAN; HIV SEROPOSITIVITY; HUMANS; MALE; SARCOMA, KAPOSI; SEX DISTRIBUTION;

EID: 36049020931     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(07)80045-3     Document Type: Article

References (63)

1. Stebbing J., and Bower M. What can oncologists learn from HIV?. Lancet Oncol 4 (2003) 438-445
2. Palella Jr. F., Delaney K., Moorman A., et al., HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
3. Portsmouth S., Stebbing J., Gill J., et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17 (2003) F17-F22
4. Stebbing J., Gazzard B., Mandalia S., et al. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 22 (2004) 2177-2183
5. Weiss R., Mitrou P., Arasteh K., et al. Acquired immunodeficiency syndrome-related lymphoma: Simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival-results of the German Multicenter Trial. Cancer 106 (2006) 1560-1568
6. Mounier N., Spina M., Gabarre J., et al. AIDS-related non-Hodgkin lymphoma: Final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 107 (2006) 3832-3840
7. Gallafent J., Buskin S., De Turk P., and Aboulafia D. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 23 (2005) 1253-1260
8. Health Protection Agency. HIV and sexually transmitted infections. Available at. http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/default.htm
9. Report on the global AIDS epidemic: A UNAIDS 10th anniversary special edition. Geneva, Switzerland. UNAIDS (2006) 1-629
10. Prins M., Meyer L., and Hessol N. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. Aids 19 (2005) 357-370
11. Centers for Disease Control (CDC). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 36 Suppl 1 (1987) 1S-15S
12. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 41 (1992) 1-19
13. Bower M., Mazhar D., and Stebbing J. Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?. J Clin Oncol. 24 (2006) 2417-2419
14. Goedert J., Cote T., Virgo P., et al. Spectrum of AIDS-associated malignant disorders. Lancet 351 (1998) 1833-1839
15. Grulich A., Wan X., Law M., et al. Risk of cancer in people with AIDS. AIDS 13 (1999) 839-843
16. Frisch M., Biggar R., Engels E., Goedert J., and AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285 (2001) 1736-1745
17. Mbulaiteye S., Biggar R., Goedert J., and Engels E. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32 (2003) 527-533
18. Franceschi S., Dal Maso L., Pezzotti P., et al., Cancer and AIDS Registry Linkage Study. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr 34 (2003) 84-90
19. Newnham A., Harris J., Evans H., et al. The risk of cancer in HIV-infected people in southeast England: A cohort study. Br J Cancer 92 (2005) 194-200
20. Lyter D., Bryant J., Thackeray R., et al. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 13 (1995) 2540-2546
21. Serraino D., Boschini A., Carrieri P., et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 14 (2000) 553-559
22. Gallagher B., Wang Z., Schymura M., et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am I Epidemiol 154 (2001) 544-556
23. Clifford G., Polesel J., Rickenbach M., et al., Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 (2005) 425-432
24. Dal Maso L., Franceschi S., Polesel J., et al., Cancer and AIDS Registry Linkage Study. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 89 (2003) 94-100
25. Kaposi M. Idiopathisches multiples Pigmentsarkom der haut. Archiv fur Dermatologie und Syphilis 4 (1872) 265-273
26. Centers for Disease Control (CDC) .Kaposi's sarcoma and pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep 30 (1981) 305-308
27. Beral V., Peterman T., Berkelman R., and Jaffe H. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?. Lancet 335 (1990) 123-128
28. Chang Y., Cesarman E., Pessin M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
29. King L. Dr. Koch's postulates. J Hist Med Allied Sci 7 (1952) 350-361
30. Koelle D., Huang M., Chandran B., et al. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J Infect Dis 176 (1997) 94-102
31. LaDuca J., Love J., Abbott L., et al. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J Infect Dis 178 (1998) 1610-1615
32. Calabro M., Fiore J., Favero A., et al. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 179 (1999) 1534-1537
33. Mocroft A., Kirk O., Clumeck N., et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA Study. Cancer 100 (2004) 2644-2654
34. Serraino D., Angeletti C., Carrieri M., et al., Immunesuppression and Cancer Study Group. Kaposi's sarcoma in transplant and HIV-infected patients: An epidemiologic study in Italy and France. Transplantation 80 (2005) 1699-1704
35. HESonline. Hospital episode statistics, 1989-99 to 2005-06. Available at. http://www.hesonline.nhs.uk
36. Martin J., Ganem D., Osmond D., et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338 (1998) 948-954
37. Smith N., Sabin C., Gopal R., et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180 (1999) 600-606
38. Dedicoat M., and Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 88 (2003) 1-3
39. Wabinga H., Parkin D., Wabwire-Mangen F., and Mugerwa J. Cancer in Kampala, Uganda, in 1989-91: Changes in incidence in the era of AIDS. Int J Cancer 54 (1993) 26-36
40. Mbulaiteye S., Katabira E., Wabinga H., et al. Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118 (2006) 985-990
41. de-The G., Bestetti G., van Beveren M., and Gessain A. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst 91 (1999) 1888-1889
42. Mayama S., Cuevas L., Sheldon J., et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77 (1998) 817-820
43. Whitby D., Luppi M., Sabin C., et al. Detection of antibodies to human herpesvirus 8 in Italian children: Evidence for horizontal transmission. Br J Cancer 82 (2000) 702-704
44. Mbulaiteye S., Pfeiffer R., Whitby D., et al. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 187 (2003) 1780-1785
45. Plancoulaine S., Abel L., van Beveren M., et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356 (2000) 1062-1065
46. Brayfield B., Kankasa C., West J., et al. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: Implications for transmission [published correction appears in J Infect Dis. 2004;190:1202]. J Infect Dis. 189 (2004) 2260-2270
47. Mbulaiteye S., Marshall V., Bagni R., et al. Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 193 (2006) 1250-1257
48. International Collaboration on HIV and Cancer .Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92 (2000) 1823-1830
49. Bower M., Fox P., Fife K., et al. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS 13 (1999) 2105-2111
50. Bower M., Nelson M., Young A., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23 (2005) 5224-5228
51. Martinez V., Caumes E., Gambotti L., et al. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer 94 (2006) 1000-1006
52. Stebbing J., Sanitt A., Nelson M., et al. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet 367 (2006) 1495-1502
53. Nasti G., Serraino D., Ridolfo A., et al. AIDS-associated Kaposi's sarcoma is more aggressive in women: A study of 54 patients. J Acquit Immune Defic Syndr Hum Retrovirol 20 (1999) 337-341
54. Meditz A., Borok M., MaWhinney S., et al. Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe. J Acquir Immune Defic Syndr 44 (2007) 306-308
55. Lunardi-Iskandar Y., Bryant J., Zeman R., et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone [published correction appears in Nature. 1995;376:447[. Nature 375 (1995) 64-68
56. Butler S., and Iles R. Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: Is there a connection?. Clin Cancer Res. 9 (2003) 4666-4673
57. Stebbing J., Mazhar D., Lewis R., et al. The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. Ann Oncol 17 (2006) 503-506
58. Harwood A., Osoba D., Hofstader S., et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 67 (1979) 759-765
59. Penn I. Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol 12 (1983) 1-10
60. Franceschi S., and Serraino D. Kaposi's sarcoma and KSHV. Lancet 346 (1995) 1360-1361
61. Farge D., and Collaborative Transplantation Research Group of Ile de France. Kaposi's sarcoma in organ transplant recipients. Eur J Med 2 (1993) 339-343
62. Sheldon J., Henry S., Mourad M., et al. Human herpes virus 8 infection in kidney transplant patients in Belgium. Nephrol Dial Transplant 15 (2000) 1443-1445
63. Regamey N., Tamm M., Wernli M., et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339 (1998) 1358-1363